Zengwu Yao

409 total citations
16 papers, 282 citations indexed

About

Zengwu Yao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zengwu Yao has authored 16 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zengwu Yao's work include Gastric Cancer Management and Outcomes (4 papers), Gut microbiota and health (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Zengwu Yao is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Gut microbiota and health (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Zengwu Yao collaborates with scholars based in China and United States. Zengwu Yao's co-authors include Shougen Cao, Shanglong Liu, Zhiliang Wei, Dongfeng Zhang, Yanbing Zhou, Yi Li, Bin Tan, Zhenbin Zhang, Zheng Lian and Song Wang and has published in prestigious journals such as Medicine, Oncotarget and Heliyon.

In The Last Decade

Zengwu Yao

12 papers receiving 280 citations

Peers

Zengwu Yao

ONCOL

SURGE

PRM

TaChung Yu China

Zibin Tian China

Qijin He China

Annie Calvé Canada

Guoping Wang China

Cristhine Pastorini United States

Cihua Zheng China

Die Dai China

Qin Sun China

Xiaokai Wang China

TaChung Yu China

Zengwu Yao

234 ×1.3

85 ×0.8

ONCOL

57 ×1.1

SURGE

27 ×0.6

PRM

29 ×0.7

Citations per year, relative to Zengwu Yao Zengwu Yao (= 1×) peers TaChung Yu

Countries citing papers authored by Zengwu Yao

Since Specialization

Citations

This map shows the geographic impact of Zengwu Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengwu Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengwu Yao more than expected).

Fields of papers citing papers by Zengwu Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengwu Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengwu Yao. The network helps show where Zengwu Yao may publish in the future.

Co-authorship network of co-authors of Zengwu Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zengwu Yao. A scholar is included among the top collaborators of Zengwu Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengwu Yao. Zengwu Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yao, Zengwu, et al.. (2025). A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer. Discover Oncology. 16(1). 76–76.

Jiang, Fangjie, Mi Jian, Yifei Zhang, et al.. (2025). High glycemic variability serves as an independent risk factor for postoperative infection-related complications in patients undergoing radical surgery for gastric, colon, and rectal cancer. Medicine. 104(7). e41602–e41602.

Jian, Mi, Fangjie Jiang, Aina Liu, et al.. (2025). PDPN+ cancer-associated fibroblasts correlate with the neoadjuvant immunotherapy response in gastric cancer. APL Bioengineering. 9(3). 36115–36115.

Yao, Zengwu, Junping Han, Jinhui Wu, et al.. (2024). Deciphering the multidimensional impact of IGFBP1 expression on cancer prognosis, genetic alterations, and cellular functionality: A comprehensive Pan-cancer analysis. Heliyon. 10(18). e37402–e37402. 1 indexed citations

Yao, Zengwu, et al.. (2024). Risk signature of NETosis‐related subtype predicts prognosis and evaluates immunotherapy effectiveness in gastric cancer. Translational Cancer Research. 13(10). 5165–5177.

Yao, Zengwu, et al.. (2024). Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study. Medicine. 103(29). e38979–e38979. 1 indexed citations

Yao, Zengwu, Hongping Chen, Yifei Zhang, et al.. (2022). Efficacy of the Short-Term versus Long-Term Administration of Antimicrobial Prophylaxis in Gastric Cancer Surgery: A Meta-Analysis of Randomized Controlled Trials. Surgical Infections. 23(7). 625–633. 3 indexed citations

Cai, Li, et al.. (2020). Fisetin attenuates gastric mucosal lesions through modulating nuclear factor-kappa B and peroxisome proliferator-activated receptor-γ in rats. Pharmacognosy Magazine. 16(71). 605–605. 4 indexed citations

Wei, Zhiliang, Shougen Cao, Xiaojie Tan, et al.. (2019). A pilot study on clinicopathological features and intestinal microflora changes in colorectal cancer patients born over a nine-year period encompassing three years before and after the Great Chinese famine. Cancer Epidemiology. 59. 166–172. 8 indexed citations

10.

Yao, Zengwu, Lixin Jiang, Yifei Zhang, et al.. (2019). What is the Short-Term Effect of a Dose of Antibiotics on Gut Microbiota in Thyroid Cancer Patients After Surgery? An Observational Clinical Study. 2(1). 1 indexed citations

11.

Yu, Yongyang, et al.. (2018). Dehydrocostus lactone inhibits in vitro gastrinoma cancer cell growth through apoptosis induction, sub-G1 cell cycle arrest, DNA damage and loss of mitochondrial membrane potential. Archives of Medical Science. 15(3). 765–773. 22 indexed citations

12.

Wei, Zhiliang, Bin Tan, Shougen Cao, et al.. (2017). The influence of neoadjuvant chemotherapy on gastric cancer patients’ postoperative infectious complications: What is the negative role played by the intestinal barrier dysfunction?. Oncotarget. 8(26). 43376–43388. 10 indexed citations

13.

Wei, Zhiliang, Shougen Cao, Shanglong Liu, et al.. (2016). Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism. Oncotarget. 7(29). 46158–46172. 169 indexed citations

14.

Jiang, Lixin, Zengwu Yao, Yifei Zhang, et al.. (2016). Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists. Chinese Journal of Cancer Research. 28(5). 511–518. 18 indexed citations

15.

Liu, Shanglong, Yanbing Zhou, Zengwu Yao, et al.. (2016). Evolutionary biologic changes of gut microbiota in an ‘adenoma-carcinoma sequence’ mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Oncotarget. 8(1). 444–457. 44 indexed citations

16.

Yao, Zengwu & Yanbing Zhou. (2013). [Progress of research in the relationship between microorganisms and colorectal cancer].. PubMed. 16(11). 1127–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact